Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.
We’re excited to announce the publication of our first CSR Report!
Happy New Year from HTL Biotechnology !
Feel the difference with HTL inside
Feel the difference with HTL inside
A global company with a heart in Brittany
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.
Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.
As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :